FDA Approves One of a Kind Drug for Rheumatoid Arthritis FDA Approves One of a Kind Drug for Rheumatoid Arthritis

By Rheumatoid Connect StaffA Published at January 24, 2013

The Food and Drug Administration (FDA) recently approved tofacitinib for treating rheumatoid arthritis (RA) patients who have not responded well to traditional RA therapy.